SCHEMBL7048727

SCHEMBL7048727

CNCCC(Oc1cccc(C(F)(F)F)c1)c1ccc(F)cc1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A4 P31645 15/20 0.64
SLC6A2 P23975 7/20 0.60
MEN1 O00255 4/20 0.60
KMT2A Q03164 4/20 0.60
LMNA P02545 4/20 0.60
CYP2D6 P10635 4/20 0.60
NPC1 O15118 2/20 0.60
CYP2C19 P33261 2/20 0.60
MTOR P42345 2/20 0.60
RAB9A P51151 2/20 0.60
CYP3A4 P08684 2/20 0.60
HTR2C P28335 2/20 0.60
SLC6A3 Q01959 2/20 0.60
KDM4E B2RXH2 1/20 0.60
TP53 P04637 1/20 0.60
CYP1A2 P05177 1/20 0.60
CYP2C9 P11712 1/20 0.60
ALOX15 P16050 1/20 0.60
TSHR P16473 1/20 0.60
NFKB1 P19838 1/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31006694 0.90 SLC6A4 (0.74) SLC6A4SLC6A2MEN1KMT2ALMNA
SCHEMBL9398389 0.90 SLC6A4 (0.74) SLC6A4SLC6A2MEN1KMT2ALMNA
Hydrochloric Acid SCHEMBL29839440 0.89 SLC6A4 (0.75) SLC6A4SLC6A2MEN1KMT2ALMNA
SCHEMBL4740237 0.85 SLC6A4 (0.78) SLC6A4SLC6A2MEN1KMT2ALMNA
SCHEMBL7049978 0.84 SLC6A4 (0.58) SLC6A4SLC6A2SLC6A3KCNK2KCNH2
SCHEMBL9195891 0.83 SLC6A4 (0.60) SLC6A4CYP2D6CYP2C19CYP2C9HRH3
Oxalic Acid SCHEMBL4739531 0.81 SLC6A4 (0.72) SLC6A4SLC6A2MEN1KMT2ALMNA
SCHEMBL2615211 0.80 SLC6A4 (0.85) SLC6A4SLC6A2MEN1KMT2ALMNA
SCHEMBL2615212 0.80 SLC6A4 (0.85) SLC6A4SLC6A2MEN1KMT2ALMNA
SCHEMBL14415684 0.79 SLC6A4 (0.87) SLC6A4SLC6A2MEN1KMT2ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0831799-B1 COMPOUNDS ACTIVE AT A NOVEL SITE ON RECEPTOR-OPERATED CALCIUM CHANNELS USEFUL FOR TREATMENT OF NEUROLOGICAL DISORDERS NPS PHARMA INC (US) 2003-05-02 EP claimed
EP-0399504-B1 Aryloxyphenylpropylamines their preparation and use NOVO NORDISK AS (DK) 1995-05-03 EP disclosed
US-5310756-A Aryloxyphenylpropylamines and their calcium overload blocking compositions and methods of use NOVO NORDISK A/S (DK) 1994-05-10 US disclosed
US-5145870-A Treating calcium overload in brain cells, anoxia, migraine, ischemia, epilepsy, neurodegenerative diseases NOVO NORDISK A/S (DK) 1992-09-08 US disclosed
EP-0399504-A2 Aryloxyphenylpropylamines their preparation and use NOVO NORDISK A/S (DK) 1990-11-28 EP disclosed